Unraveling the Function of PAX3-FOXO1’s Activation Domain in Rhabdomyosarcoma |
Case Western Reserve University / Berkley Gryder, PhD |
'A' Award Grants |
2023 |
Ohio |
Radiation and the Tumor Microenvironment in an Immunocompetent Model of Ewing Sarcoma |
Children’s Hospital of Pittsburgh Foundation / Jessica Daley, MD |
Young Investigator Grants |
2023 |
Pennsylvania |
Genomic and nuclear organizational changes in chemotherapy-resistant rhabdomyosarcoma cells |
Ann & Robert H. Lurie Children’s Hospital of Chicago / Kyle MacQuarrie, MD/PhD |
'A' Award Grants |
2023 |
Illinois |
Empowering specificity of AML immunotherapies by HSC engineering |
Boston Children’s Hospital / Pietro Genovese |
Catalyst Grants |
2023 |
Massachusetts |
Circumventing Pediatric Solid Tumor Microenvironment Resistance by Combinatorial CAR NK and Immunomodulating Therapy |
New York Medical College / Mitchell Cairo, MD |
Reach Grants |
2023 |
New York |
Feasibility Study of Dual Inhibition of MDM2 and Tubulin in Treatment of AML |
Emory University / Muxiang Zhou, MD |
Reach Grants |
2023 |
Georgia |
Unraveling GABAergic interneuron-like lineage in H3G34-mutant hemispheric high-grade gliomas: their impact on network formation and invasion |
Dana-Farber Cancer Institute / Gustavo Alencastro Veiga Cruzeiro, PhD |
Young Investigator Grants |
2024 |
Massachusetts |
Investigating the impact of osteosarcoma genetic lesions on bone differentiation |
Dana-Farber Cancer Institute / James Morrow, MD/PhD |
Young Investigator Grants |
2024 |
Massachusetts |
MYCN-induced molecular clock disruption and metabolic rewiring drive neuroblastoma |
Baylor College of Medicine / Lingzhi Li, PhD |
Young Investigator Grants |
2024 |
Texas |
Capitalizing on functional genomics with targeted protein degradation in neuroblastoma |
St. Jude Children’s Research Hospital / Ian Delahunty, PhD |
Young Investigator Grants |
2024 |
Tennessee |